Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 20, 2022, titled "Strides and its African subsidiary Universal Corporation partner with Medicines Patent Pool (MPP) to commercialize molnupiravir for the global markets".
Press Release Jan 20 2022
Filed with NSE · · 3 pages · English
Release
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Jan 17 2022
- Press Release Dec 28 2021
- Press Release Aug 06 2021
- Press Release Jun 28 2021
- Press Release Jun 14 2021
Later from Strides Pharma Science
- Press Release Feb 21 2022
- Press Release Mar 11 2022
- Extra Ordinary Meeting
- Newspaper Advertisements
- Press Release Mar 17 2022
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science